New Drugs of 2011, Part 2

MARCH 14, 2012
Michael A. Mancano, PharmD

Pharmacy Times Office of Continuing Professional Education

New Drugs of 2011, Part 2

Michael A. Mancano, PharmD

Clinical Professor of Pharmacy Practice

Interim Chair, Department of Pharmacy Practice

Temple University School of Pharmacy; Philadelphia, PA

Clinical Consultant, Department of Pharmacy

Pennsylvania Hospital; Philadelphia, PA

Michael A. Mancano, PharmD, has no relevant affiliations or financial relationships to disclose.

Judy V. Lum, MPA; Ann C. Lichti, CCMEP; and Donna Fausak of the Pharmacy Times Office of Continuing Professional Education have no relevant affiliations or financial relationships to disclose related to this activity.

Educational Objectives

Upon completing the program, participants should be able to:

  1. Discuss the clinical indications of 8 new drugs approved by the FDA in 2011.
  2. Explain the mechanisms of action of the drugs discussed within this program.
  3. Recognize the clinically relevant drug interactions for the drugs reviewed in this program.
  4. Identify the most common adverse reactions for the discussed new drug approvals.
  5. Explain the approved dosing guidelines and recommended dosage adjustments for the drugs reviewed.

Target audience: Pharmacists

Type of activity: Knowledge

Release date: February 10, 2012

Expiration date: February 10, 2014

Estimated time to complete activity: 2.0 hours

Fee: There is no charge for taking this course online.

Click here to view this activity.


Immunization Laws Around the Nation

Many areas of medicine that intersect with law and immunizations are associated with a very specific set of laws across the nation.  


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.